Delivery Order SPE2DB25D3108-SPE2DB25FPDFD

Award Date 7/1/25
Potential Completion Date 7/2/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $7,399.22 and a performance period through May 12, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dupixent 300 mg/2 ml syringe, a pharmaceutical product. The contract has a ceiling value of $3,418.92 and a completion date of June 30, 2025. The contract type is Firm Fixed Price. There is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.46, is for the delivery of 300 mg/2 mL syringes of the drug Dupixent. The contract is a firm fixed-price delivery order with a completion date of July 2, 2025. The contract is not set aside and was awarded on July 1, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Dupixent 300 mg/2 ml syringes. The contract has a ceiling value of $2,822.48 and is set to expire on January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a prescription medication, with a ceiling value of $10,350.00 and a period of performance through April 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg/2 mL Dupixent syringes. The contract has a ceiling value of $29,132.95 and is a firm fixed-price delivery order, with a period of performance extending through June 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Dupixent 300 mg/2 ml syringes. The contract has a firm fixed price, with a ceiling value of $5,128.38, and an ultimate completion date of July 3, 2025. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,837.84, is for the delivery of 4,567,874,487 units of the medication Dupixent 300 mg/2 ml syringe. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 11, 2025. This order is not associated with a set-aside program and is open to full and open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 300 mg/2 mL syringes of the prescription medication Dupixent, with a ceiling value of $16,203.93 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 200 mg/1.14 ml syringes. The contract has a ceiling value of $13,675.68 and an ultimate completion date of June 27, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPDFD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 300 mg/2 ml syringes of the drug Dupixent, with a ceiling value of $11,116.86 and a period of performance ending on July 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is part of the company's broader federal contracting portfolio, which involves supplying a wide range of pharmaceutical products and medical supplies to support military and other government healthcare programs.

Generated 10/5/25, 1:08 AM